Virtus ETF Advisers’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,029
Closed -$61.7K 387
2024
Q4
$61.7K Sell
3,029
-1,135
-27% -$23.1K 0.03% 440
2024
Q3
$121K Buy
4,164
+72
+2% +$2.1K 0.06% 351
2024
Q2
$95K Buy
4,092
+357
+10% +$8.29K 0.05% 336
2024
Q1
$76.6K Sell
3,735
-259
-6% -$5.32K 0.04% 398
2023
Q4
$85.7K Buy
3,994
+949
+31% +$20.4K 0.05% 414
2023
Q3
$62.8K Sell
3,045
-304
-9% -$6.27K 0.04% 401
2023
Q2
$98.8K Buy
3,349
+56
+2% +$1.65K 0.06% 388
2023
Q1
$75.9K Sell
3,293
-1,259
-28% -$29K 0.04% 392
2022
Q4
$127K Sell
4,552
-323
-7% -$8.98K 0.07% 400
2022
Q3
$150K Buy
4,875
+36
+0.7% +$1.11K 0.06% 354
2022
Q2
$142K Buy
4,839
+1,406
+41% +$41.3K 0.05% 326
2022
Q1
$110K Sell
3,433
-200
-6% -$6.41K 0.05% 287
2021
Q4
$162K Buy
3,633
+803
+28% +$35.8K 0.06% 320
2021
Q3
$143K Sell
2,830
-150
-5% -$7.58K 0.06% 349
2021
Q2
$234K Sell
2,980
-664
-18% -$52.1K 0.1% 231
2021
Q1
$208K Buy
3,644
+58
+2% +$3.31K 0.09% 322
2020
Q4
$300K Sell
3,586
-8,878
-71% -$743K 0.12% 211
2020
Q3
$447K Sell
12,464
-1,710
-12% -$61.3K 0.23% 147
2020
Q2
$343K Sell
14,174
-4,846
-25% -$117K 0.16% 272
2020
Q1
$333K Sell
19,020
-2,785
-13% -$48.8K 0.14% 216
2019
Q4
$380K Buy
21,805
+8,311
+62% +$145K 0.06% 275
2019
Q3
$207K Sell
13,494
-752
-5% -$11.5K 0.04% 242
2019
Q2
$296K Buy
14,246
+1,045
+8% +$21.7K 0.06% 223
2019
Q1
$307K Sell
13,201
-1,589
-11% -$37K 0.65% 59
2018
Q4
$306K Sell
14,790
-10,928
-42% -$226K 0.05% 107
2018
Q3
$559K Sell
25,718
-18,899
-42% -$411K 0.06% 108
2018
Q2
$680K Buy
+44,617
New +$680K 0.6% 107